We further investigated the predictive value of PKM2 expression within patient subgroups and found that the prognostic significance of PKM2 retained within the Edmondson I-II, Edmondson III-IV, single tumor, AFP ≤ 20 ng/mL, and TNM stage I subgroups (Fig. 5D). This evidence concerns the gene AFP and neoplasm.